Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>
Idioma: En

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor: Camostat mesylate, an inhibitor of TMPRSS2, blocks SARS-CoV-2 infection of lung cells.


https://ift.tt/2QjCvTM via /r/science https://ift.tt/38RQDtD March 17, 2020 at 02:55AM


This post first appeared on Learn Everything Fast, please read the originial post: here

Share the post

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor: Camostat mesylate, an inhibitor of TMPRSS2, blocks SARS-CoV-2 infection of lung cells.

×

Subscribe to Learn Everything Fast

Get updates delivered right to your inbox!

Thank you for your subscription

×